“Although the CDC’s pending guidance on opioid prescribing — expected to be some of the strongest federal advice on opioids to date — was supposed to drop this month, politics have forced the agency into an additional public comment period.
That has some experts wondering whether strong advice about supply and dosing limits will be preserved.
“I think that having input from as many perspectives as possible will strengthen the applicability and acceptability,” Lewis Nelson, MD, of NYU Langone Medical Center, who was an advisor to the draft guidelines, told MedPage Today. “However, the focus on benefit versus risk should not be diluted. This has been a shortcoming of some prior opioid guidelines.”
Although the guidance won’t be legally binding, its impact is predicted to be dramatic — prompting several groups, some with ties to opioid drugmakers, to work hard against it. Thousands of comments have been submitted to the agency, many of them critical of various elements in the recommendations as well as the process under which they were developed.”
Source: MedPageToday.com – January 8, 2015